Figure 1 - uploaded by Fatin Hanisah Firman
Content may be subject to copyright.
Source publication
Few cases of chalazia secondary to bortezomib are reported in literature. However, it is not a recognized ocular adverse effect. We hereby report a case of recurrent chalazia secondary to bortezomib. A 40-year-old male with light chain myeloma on ten weeks of chemotherapy with bortezomib was treated for left eye inflamed chalazion with bilateral me...
Context in source publication
Similar publications
Purpose
To investigate the usefulness of diathermy thermocoagulation in chalazion surgery.
Methods
This prospective, observational study included 30 sides from 24 patients who underwent chalazion surgery using diathermy thermocoagulation. The eyelid was fixed with a chalazion clamp under local anesthesia. The skin or palpebral conjunctiva was inci...
Sebaceous carcinoma (SebCa), is the second most frequent malignancy of the eyelid. It often presents with non-specific clinical features and is known for mimicking benign inflammatory lesions such as chalazion. The masquerading ability of this highly invasive neoplasm can delay or mislead the diagnosis, resulting in significant morbidity and mortal...
Objective
To report the influence of Demodex folliculorum (D. folliculorum) infestation in patients with meibomian gland dysfunction (MGD) related dry eye and the associations of the infestation with MGD related dry eye.
Methods
Eyelashes (three from the upper eyelid and three from the lower eyelid) from 119 eyes of 119 patients diagnosed with MGD...
![Zernike modes and their common names [12,13]](publication/342489161/figure/tbl1/AS:906919438999553@1593237852305/Zernike-modes-and-their-common-names-12-13_Q320.jpg)
Aim This study investigated the correlation between chalazion, regarding its size, site and location, and different types of refractive errors, as well as high-order aberrations in Egyptian patients.
Patients and methods This is a cross-sectional study which compared 53 eyes from 48 patients having eyelid chalazion with 43 eyes of age-matched contr...
Background: Chalazion is a common eyelid disease caused by plugged meibomian glands and chronic lipogranulomatous inflammation. It can affect individuals of all ages and may cause local eye symptoms such as irritation and inflammation and cosmetic disfigurement. There are mainly three methods of treating chalazion: Intralesional Triamcinolone Aceto...
Citations
Purpose: This study reports a case of meibomian gland dysfunction associated with bortezomib, which is a treatment of choice for multiple myeloma.Case summary: A 59‐year‐old female patient presented to our hospital with a complaint of dryness that had worsened for 2 months and eye discharges that were difficult to remove even after washing her face. The patient had been diagnosed with multiple myeloma 5 months prior and had undergone four cycles of bortezomib therapy. Slit‐lamp microscopy revealed a number of pouting of the meibomian gland (MG) orifices in both eyes. Meibography revealed that more than one‐third and less than twothirds of the total MG area of both upper lids were lost and more than two‐thirds of the total MG area of both lower lids were lost. No clinically significant improvements were noted at 8 months despite thorough eyelid hygiene therapy, including warm compresses, topical antibiotics, steroids, and artificial tears. However, when the patient revisited our clinic 2 months after completing bortezomib treatment, the subjective symptoms had improved and all of the pouting of MG orifices had disappeared. There was no significant difference in the MG dropout area for either eye compared with the observations from a previous visit during bortezomib treatment.Conclusions: Clinicians should be aware that MG dysfunction may occur or worsen in patients receiving bortezomib treatment and should consider this when establishing a treatment plan for meibomian dysfunction or when educating patients.
